CERVOMED INC. DL-,001

Share · US15713L1098 · DFFN · A3ES01 (XNCM)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

19.12.2025 21:03

Current Prices from CERVOMED INC. DL-,001

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	CRVO	USD	19.12.2025 21:03	7,60 USD	-0,32 USD -4,04 %
Frankfurt	DP8.F	EUR	19.12.2025 07:03	6,60 EUR	-0,05 EUR -0,75 %

Share Float & Liquidity

Free Float 58,61 %

Shares Float 5,42 M

Shares Outstanding 9,25 M

Company Profile for CERVOMED INC. DL-,001 Share

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.

AI Analysis of CERVOMED INC. DL-,001

Click any analysis below to get instant AI insights from finAgent

Company Data

Name CERVOMED INC. DL-,001

Company Diffusion Pharmaceuticals Inc.

Symbol DFFN

Website https://www.diffusionpharma.com

Primary Exchange

Frankfurt

WKN A3ES01

ISIN US15713L1098

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Robert J. Cobuzzi Jr.,

Country United States of America

Currency EUR

Employees 0,0 T

Address 300 East Main Street, 22902 Charlottesville

IPO Date 2008-05-23

ID Changes

Date	From	To
17.08.2023	DFFN	CRVO

Ticker Symbols

Name	Symbol
Frankfurt	DP8.F
NASDAQ	CRVO
NASDAQ	DFFN

More Shares

Investors who hold CERVOMED INC. DL-,001 also have the following shares in their portfolio:

FLIGHT CENTRE TRAVEL GRP Share

INTERNATIONAL FINANCE CORPORATION ZRO CPN CALL ACC NTS 22/09/46 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog